Stocks to watch:

Ultragenyx CEO: Committed to helping patients pay for dru...

Now watching

Next video starts in : 7 Play

Ultragenyx CEO: Committed to helping patients pay for dru...

Ultragenyx CEO: Committed to helping patients pay for dru...
Replay video
Up next

Who wants to smoke Cubans?

Unlock your personal NFL Now stream by signing in to NFL.com

Ultragenyx CEO: Committed to helping patients pay for dru...

by CNBC Videos 2:53 mins

Ultragenyx is now up around 150 percent from its IPO price. Its CEO Dr. Emil Kakkis provides insight on the development of its drugs, and just how committed the company is to treating patients with the diseases its drugs treat.

View Comments (0)